Odyssey Therapeutics Acquires Quantum Drug Discovery Startup Rahko

In another cross-the-pond deal, US-based Odyssey Therapeutics acquired London-based Rahko, according to reports from The Telegraph. Rahko is developing quantum computer software designed for drug discovery. Odyssey is based in Boston. The amount of the acquisition was not made. According to the reports, Odyssey acquired a majority stake in the startup that is using quantum […]Read More